Skip to content

Taste Assessment of Ozanimod

An Open-Label Taste Assessment of Ozanimod in Healthy Subjects

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05001152
Enrollment
7
Registered
2021-08-11
Start date
2021-09-09
Completion date
2021-09-27
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Ozanimod

Brief summary

The purpose of this study is to assess the taste characteristics of ozanimod formulations, alone and mixed, in order to develop a pediatric oral form of ozanimod.

Interventions

DRUGOzanimod

Taste assessment

Sponsors

Bristol-Myers Squibb
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women, between 25 and 80 years of age. * Participant is a qualified sensory panelist selected by Senopsys based on training and experience

Exclusion criteria

* Participant has any history of any illness, medical condition, laboratory abnormality, or psychiatric illness that might confound the results of the study or places the panelist at unacceptable risk if he or she were to participate in the study. * Participant is a female that is pregnant, nursing, or planning to become pregnant during the study. Other protocol-defined inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Taste evaluation - Aromatic identityUp to 6 monthsMeasured using the Flavor Profile method of descriptive sensory analysis
Taste evaluation - AmplitudeUp to 6 monthsMeasured using the Flavor Profile method of descriptive sensory analysis
Taste evaluation - Off-notesUp to 6 monthsMeasured using the Flavor Profile method of descriptive sensory analysis
Taste evaluation - AftertasteUp to 6 monthsMeasured using the Flavor Profile method of descriptive sensory analysis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026